Mri Ultrasound Fusion(磁共振超声融合)研究综述
Mri Ultrasound Fusion 磁共振超声融合 - A total of 289 patients underwent targeted mpMRI-ultrasound fusion-guided prostate biopsy complemented by systematic biopsy. [1] Treatment outcomes were assessed by combined mpMRI-ultrasound fusion-guided and extended sextant systematic biopsy after 12, 24, and optionally after 36 months. [2] METHODS In this non-randomized observational study, we recruited 105 patients who underwent TR or TP software-based MRI-ultrasound fusion prostate biopsies between April and August 2020. [3] A total of 400 consecutive patients with suspected cancer lesions who underwent MRI-ultrasound fusion biopsy and subsequent prostatectomy were included. [4] MATERIALS AND METHODS In our institutional mpMRI-ultrasound fusion biopsy database, 173 underwent targeted and systematic biopsy followed by radical prostatectomy (RP). [5] Beyond this, several techniques are available, including cognitive registration, MRI-Ultrasound fusion imaging and direct MRI in-bore guided biopsy. [6]共有 289 名患者接受了靶向 mpMRI-超声融合引导的前列腺活检并辅以系统活检。 [1] 在 12、24 和可选的 36 个月后，通过联合 mpMRI-超声融合引导和扩展六分仪系统活检评估治疗结果。 [2] 方法 在这项非随机观察性研究中，我们招募了 105 名在 2020 年 4 月至 2020 年 8 月期间接受基于 TR 或 TP 软件的 MRI 超声融合前列腺活检的患者。 [3] 共纳入 400 名连续接受 MRI-超声融合活检和随后的前列腺切除术的疑似癌症病变患者。 [4] 材料和方法 在我们的机构 mpMRI-超声融合活检数据库中，173 例接受了靶向和系统活检，然后进行了根治性前列腺切除术 (RP)。 [5] 除此之外，还有几种技术可供使用，包括认知配准、MRI-超声融合成像和直接 MRI 孔内引导活检。 [6]
clinically significant prostate 有临床意义的前列腺
OBJECTIVES To explore whether prostate-specific antigen (PSA) affects the choice of prostate puncture methods by comparing MRI-ultrasound fusion targeted biopsy (MRI-TBx) with transrectal ultrasound systematic biopsy (TRUS-SBx) in the detection of prostate cancer (PCa), clinically significant prostate cancer (csPCa) and non-clinically significant prostate cancer (nsPCa) in different PSA groups (<10. [1] STANDARD RADIOLOGICAL METHODS Image-guided biopsy techniques such as MRI-ultrasound fusion not only allow guidance for targeted tissue sampling of index lesions for diagnostic confirmation, but also improve the detection of clinically significant prostate cancer. [2] INTRODUCTION Multiparametric (mp) MRI-Ultrasound fusioned biopsy (Fbx) has emerged as the new standard of risk stratification for prostate cancer with superior detection rates of clinically significant prostate cancer (PCa) than randomized biopsy. [3]目标 通过比较 MRI-超声融合靶向活检 (MRI-TBx) 与经直肠超声系统活检 (TRUS-SBx) 在前列腺癌 (PCa) 检测中的作用，探讨前列腺特异性抗原 (PSA) 是否影响前列腺穿刺方法的选择，不同 PSA 组中具有临床意义的前列腺癌 (csPCa) 和非临床意义的前列腺癌 (nsPCa) (<10. [1] 标准放射学方法 MRI-超声融合等影像引导活检技术不仅可以指导对指标病灶进行靶向组织取样以进行诊断确认，而且还可以提高对临床意义重大的前列腺癌的检测。 [2] nan [3]
suspected prostate cancer 疑似前列腺癌
MATERIALS AND METHODS We collected data from a cohort of 971 men who underwent MRI-ultrasound fusion targeted biopsy for suspected prostate cancer. [1] MATERIALS AND METHODS Between May 2015 and October 2017, a total of 408 patients were referred to our clinic for MRI-ultrasound fusion targeted biopsy of the prostate (FusPbx) due to suspected prostate cancer. [2] The purpose of this article is to evaluate restriction spectrum imaging (RSI) in men undergoing MRI-ultrasound fusion biopsy for suspected prostate cancer (PCa) and to compare the performance of RSI with that of conventional DWI. [3]材料和方法 我们收集了一组 971 名男性的数据，这些男性因疑似前列腺癌而接受了 MRI-超声融合靶向活检。 [1] nan [2] nan [3]